The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 25464856)

Published in Immunity on November 13, 2014

Authors

Matthew M Staron1, Simon M Gray1, Heather D Marshall1, Ian A Parish1, Jonathan H Chen1, Curtis J Perry1, Guoliang Cui1, Ming O Li2, Susan M Kaech3

Author Affiliations

1: Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
2: Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
3: Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Howard Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase, MD 20815-6789, USA. Electronic address: susan.kaech@yale.edu.

Articles citing this

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell (2015) 3.03

Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol (2015) 2.74

Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. Cell (2015) 2.60

Overcoming T cell exhaustion in infection and cancer. Trends Immunol (2015) 1.72

Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science (2016) 1.39

Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion. Immunity (2016) 1.27

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Immunity (2016) 1.26

The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells. Immunity (2015) 1.20

Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function. Immunity (2015) 1.09

Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells. J Exp Med (2015) 1.06

Inhibitory Receptors Beyond T Cell Exhaustion. Front Immunol (2015) 1.05

New immunotherapies targeting the PD-1 pathway. Trends Pharmacol Sci (2015) 1.02

The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients. Oncotarget (2015) 0.99

Synchronizing transcriptional control of T cell metabolism and function. Nat Rev Immunol (2015) 0.97

Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family. Immunity (2016) 0.96

mTOR Links Environmental Signals to T Cell Fate Decisions. Front Immunol (2015) 0.93

Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection. Nat Med (2015) 0.91

Innate and Adaptive Immune Regulation During Chronic Viral Infections. Annu Rev Virol (2015) 0.89

Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease. Immunity (2016) 0.88

Feeding an army: The metabolism of T cells in activation, anergy, and exhaustion. Mol Immunol (2015) 0.87

Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses. Immunity (2016) 0.84

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma. Oncotarget (2015) 0.83

Cancer immunotherapies targeting the PD-1 signaling pathway. J Biomed Sci (2017) 0.82

Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host. Cell Rep (2016) 0.82

Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity. Vaccines (Basel) (2015) 0.81

Metabolic communication in tumors: a new layer of immunoregulation for immune evasion. J Immunother Cancer (2016) 0.81

Genetic and Epigenetic Regulation of PD-1 Expression. J Immunol (2016) 0.80

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation. Front Immunol (2016) 0.80

Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy. Cancer Discov (2016) 0.79

Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma. Immunol Rev (2017) 0.78

Age-related changes in the transcriptome of antibody-secreting cells. Oncotarget (2016) 0.77

mTOR Regulation of Lymphoid Cells in Immunity to Pathogens. Front Immunol (2016) 0.77

Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion. J Virol (2016) 0.76

IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8+ T Cells Responding to Persistent LCMV Infection. PLoS One (2015) 0.76

Metabolic Instruction of Immunity. Cell (2017) 0.76

Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE. J Biol Chem (2016) 0.76

Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy. Front Oncol (2017) 0.75

Exhaustion-associated regulatory regions in CD8(+) tumor-infiltrating T cells. Proc Natl Acad Sci U S A (2017) 0.75

IL2Rβ-dependent signals drive terminal exhaustion and suppress memory development during chronic viral infection. Proc Natl Acad Sci U S A (2016) 0.75

Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion. J Exp Med (2016) 0.75

The discontinuity theory of immunity. Sci Immunol (2016) 0.75

Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity. Proc Natl Acad Sci U S A (2017) 0.75

Metabolic tug-of-war in tumors results in diminished T cell antitumor immunity. Oncoimmunology (2015) 0.75

Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity. Vaccines (Basel) (2016) 0.75

Cerebral Gluconeogenesis and Diseases. Front Pharmacol (2017) 0.75

Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses. Front Immunol (2017) 0.75

Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory. J Immunol (2016) 0.75

Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8(+) T Cell Responses to Chronic Viral Infections and Cancer. Front Immunol (2017) 0.75

Transient expression of ZBTB32 in anti-viral CD8+ T cells limits the magnitude of the effector response and the generation of memory. PLoS Pathog (2017) 0.75

TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1. J Immunol (2017) 0.75

CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation. Cell Death Differ (2017) 0.75

Programmed death 1 is highly expressed on CD8+CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to EBV. Immunology (2017) 0.75

Transcriptional and epigenetic regulation of T cell hyporesponsiveness. J Leukoc Biol (2017) 0.75

Articles cited by this

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32

Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2005) 28.04

PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol (2008) 19.24

T cell exhaustion. Nat Immunol (2011) 11.08

mTOR regulates memory CD8 T-cell differentiation. Nature (2009) 10.07

Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature (2009) 8.09

Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci U S A (1999) 7.70

Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature (1989) 7.52

FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene (2005) 7.50

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med (2009) 6.80

The CD28 signaling pathway regulates glucose metabolism. Immunity (2002) 6.65

Redefining chronic viral infection. Cell (2009) 6.30

Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell (2013) 6.30

The FoxO code. Oncogene (2008) 6.22

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol (2005) 6.18

The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity (2011) 6.00

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol (2009) 5.20

SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol (2004) 4.58

Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol (2009) 4.31

The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem (2007) 4.22

The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity (2010) 4.21

A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity (2009) 3.66

Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science (2012) 3.39

Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients. J Clin Invest (2011) 3.28

Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol (2008) 3.23

Foxo transcription factors control regulatory T cell development and function. Immunity (2010) 3.17

The role of FoxO in the regulation of metabolism. Oncogene (2008) 3.09

Metabolic pathways in immune cell activation and quiescence. Immunity (2013) 3.09

Regulation of immune responses by mTOR. Annu Rev Immunol (2011) 3.08

Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J Exp Med (2007) 3.05

Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol (2010) 3.05

The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity (2010) 2.85

An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity (2009) 2.82

Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell (2012) 2.79

An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity (2011) 2.77

Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature (2012) 2.77

PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett (2004) 2.77

Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nat Immunol (2011) 2.76

PD-1 signaling in primary T cells. Immunol Rev (2009) 2.66

PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J Exp Med (2012) 2.58

Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med (2012) 2.58

Metabolism, migration and memory in cytotoxic T cells. Nat Rev Immunol (2011) 2.25

Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity (2011) 2.17

Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity (2012) 2.16

The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity (2013) 2.13

CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability. Proc Natl Acad Sci U S A (2013) 1.90

Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol (2013) 1.86

Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc Natl Acad Sci U S A (2010) 1.85

NFATc1 regulates PD-1 expression upon T cell activation. J Immunol (2008) 1.81

Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation. Immunity (2012) 1.69

FOXO transcription factors throughout T cell biology. Nat Rev Immunol (2012) 1.60

Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest (2006) 1.59

The metabolic life and times of a T-cell. Immunol Rev (2010) 1.57

PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice. J Clin Invest (2010) 1.53

PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J Exp Med (2013) 1.48

Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J Immunol (2012) 1.48

Strength of PD-1 signaling differentially affects T-cell effector functions. Proc Natl Acad Sci U S A (2013) 1.42

Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection. J Virol (2012) 1.39

Role of Bim in regulating CD8+ T-cell responses during chronic viral infection. J Virol (2006) 1.32

Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J Exp Med (2012) 1.29

Differentiation of CD8 memory T cells depends on Foxo1. J Exp Med (2013) 1.25

The transcription factor Foxo1 controls central-memory CD8+ T cell responses to infection. Immunity (2013) 1.23

In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb. J Virol (2001) 1.23

FOXO3 regulates CD8 T cell memory by T cell-intrinsic mechanisms. PLoS Pathog (2012) 1.22

Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes. J Exp Med (2009) 1.16

T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat Rev Immunol (2014) 1.11

FoxO1 controls effector-to-memory transition and maintenance of functional CD8 T cell memory. J Immunol (2013) 1.09

Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection. J Exp Med (2014) 0.99

PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2. Mol Cell Biol (2013) 0.99

FOXO3 regulates the CD8 T cell response to a chronic viral infection. J Virol (2012) 0.91

Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation. Eur J Immunol (2011) 0.85